Duchenne Muscular Dystrophy Video Assessment Registry (ARISE)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Katherine Pleasant
- Phone Number: 774-433-9313
- Email: kpleasant@emmes.com
Study Contact Backup
- Name: Mary Hubbard
- Phone Number: 888-283-1635
- Email: mhubbard@emmes.com
Study Locations
-
-
Maryland
-
Rockville, Maryland, United States, 20850
- Emmes
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- At least 2 years of age at time of consent
- Written consent (English only) by adult participant or parent/legal guardian of minor participant
- Written assent (English only) if minor participant is at least 7 years of age
- Documentation provided for the participant's diagnosis of DMD (i.e., genetic report, clinic note)
Exclusion Criteria:
Participants will be excluded if they are unable to use a hand to hold a pen, pick up pennies or drive a powerchair.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duchenne Video Assessment (DVA)
Time Frame: 24 months
|
The DVA is a home-based clinical outcome assessment that measures ease of movement through identification of compensatory movement patterns.
The DVA includes 18 standardized movement tasks that are assigned to participants based on functional subgroup.
The DVA directs and trains caregivers to video record patients doing specific movement tasks at home using a secure mobile application.
DVA videos are scored by DVA-certified physical therapists using validated scorecards with prespecified compensatory movement criteria.
|
24 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
North Star Ambulatory Assessment (NSAA)
Time Frame: 24 months
|
The NSAA is a 17-item tool used to measure functional motor abilities in ambulatory individuals with DMD.
Physical therapists with experience administering the NSAA will remotely administer and record the live NSAA sessions via a secure video conference platform.
Participants will receive the appropriate standardized testing equipment.
|
24 months
|
|
Performance of Upper Limb 2.0 (PUL 2.0)
Time Frame: 24 months
|
The PUL 2.0 is a 22-item rating scale used to measure upper limb abilities in individuals with DMD.
The test includes an entry test item to define starting functional level and 21 test items subdivided into shoulder level, elbow level, and distal level.
Physical therapists with experience administering the PUL 2.0 will remotely administer and record the live PUL 2.0 sessions via secure video conference platform.
Participants will receive the appropriate standardized testing equipment.
|
24 months
|
|
Caregiver Task-Specific Impression of Change
Time Frame: 24 months
|
At each follow-up assessment timepoint, parents/legal guardians or recording partners will complete an electronic questionnaire to rate their impression of change in the participant's ability to perform each DVA movement task since the prior timepoint.
|
24 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Marielle Contesse, PhD, Emmes Endpoint Solutions
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CAS-CAS005-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.